Literature DB >> 2539494

A neutrophil-derived antiviral protein: induction requirements and biological properties.

H B Ohmann1, M Campos, D R Fitzpatrick, N Rapin, L A Babiuk.   

Abstract

Polymorphonuclear neutrophilic granulocytes (PMN) have been implicated as playing a role in antiviral defense. In addition to having phagocytic and cytotoxic activities, PMN may produce an antiviral substance with interferon (IFN)-like activity. The product, for which the name polyferon (PF) has been coined, is produced upon direct encounter of PMN with bovine herpesvirus 1 (BHV-1)-infected bovine cells or membranes thereof. Exposure to purified virus only does not induce PF. The intimate interaction between PMN and the membranes was also revealed by electron microscopy studies. Bovine cells infected with herpes simplex virus type 1 could also induce PF production by bovine PMN, whereas cells infected with BHV-2, herpes simplex virus type 2, equine herpesvirus 1, bovine respiratory syncytial virus, bovine viral diarrhea virus, or parainfluenza virus 3 were unable to do so. Results obtained in experiments using transfected cells expressing BHV-1 glycoproteins as well as blocking experiments using BHV-1 glycoprotein-monospecific antibodies suggested that a combination of both viral product(s) and host cell factor(s) unique to bovine cells is required for induction of PF production by PMN. PF, which appeared in detectable amounts 12 to 18 h after exposure of PMN to the appropriate inducer, could not be neutralized by antibodies to bovine IFN-alpha, -beta, and -gamma. PF may nevertheless belong to the IFN family of proteins, as indicated by its ability to induce 2',5'-oligoadenyl synthetase in various cell types that are responsive to bovine IFNs and by its antiviral spectrum. It does, however, differ from the other cytokines in most immunological characteristics tested so far, including major histocompatibility complex class II antigen induction, cell migration, and cytotoxicity.

Entities:  

Mesh:

Substances:

Year:  1989        PMID: 2539494      PMCID: PMC250603     

Source DB:  PubMed          Journal:  J Virol        ISSN: 0022-538X            Impact factor:   5.103


  29 in total

1.  Immune interferon production by lymphoid cells: role in the inhibition of herpesviruses.

Authors:  L A Babiuk; B T Rouse
Journal:  Infect Immun       Date:  1976-06       Impact factor: 3.441

2.  Cellular events in zoster vesicles: relation to clinical course and immune parameters.

Authors:  D A Stevens; R A Ferrington; G W Jordan; T C Merigan
Journal:  J Infect Dis       Date:  1975-05       Impact factor: 5.226

3.  Electrophoretic transfer of proteins from polyacrylamide gels to nitrocellulose sheets: procedure and some applications.

Authors:  H Towbin; T Staehelin; J Gordon
Journal:  Proc Natl Acad Sci U S A       Date:  1979-09       Impact factor: 11.205

4.  Herpes simplex and varicella-zoster: comparative histopathology of 77 cases.

Authors:  J McSorley; L Shapiro; M H Brownstein; K C Hsu
Journal:  Int J Dermatol       Date:  1974 Mar-Apr       Impact factor: 2.736

5.  Acute and recurrent infection with herpes simplex virus in the mouse: a model for studying latency and recurrent disease.

Authors:  T J Hill; H J Field; W A Blyth
Journal:  J Gen Virol       Date:  1975-09       Impact factor: 3.891

6.  Direct inactivation of viruses by MCP-1 and MCP-2, natural peptide antibiotics from rabbit leukocytes.

Authors:  R I Lehrer; K Daher; T Ganz; M E Selsted
Journal:  J Virol       Date:  1985-05       Impact factor: 5.103

7.  Evidence for defective neutrophil function in lungs of calves exposed to infectious bovine rhinotracheitis virus.

Authors:  R L McGuire; L A Babiuk
Journal:  Vet Immunol Immunopathol       Date:  1984-01       Impact factor: 2.046

8.  Bovine type II interferon: activity in heterologous cells.

Authors:  L A Babiuk; B T Rouse
Journal:  Intervirology       Date:  1977       Impact factor: 1.763

9.  Unusual human interferons produced by virus-infected amniotic membranes.

Authors:  P Duc-Goiran; B Robert-Galliot; T Chudzio; C Chany
Journal:  Proc Natl Acad Sci U S A       Date:  1983-05       Impact factor: 11.205

10.  Studies on the in vitro biological activities of recombinant bovine tumor necrosis factor (rBoTNF) alpha. I. Synergistic antiviral efficacy of rBoTNF alpha, recombinant bovine interferon gamma (rBoIFN gamma) and their combination.

Authors:  M Campos; H B Ohmann; G Hughes; L A Babiuk; M J Lawman
Journal:  Antiviral Res       Date:  1988-11       Impact factor: 5.970

View more
  2 in total

1.  Pathogenicity of influenza viruses with genes from the 1918 pandemic virus: functional roles of alveolar macrophages and neutrophils in limiting virus replication and mortality in mice.

Authors:  Terrence M Tumpey; Adolfo García-Sastre; Jeffery K Taubenberger; Peter Palese; David E Swayne; Mary J Pantin-Jackwood; Stacey Schultz-Cherry; Alicia Solórzano; Nico Van Rooijen; Jacqueline M Katz; Christopher F Basler
Journal:  J Virol       Date:  2005-12       Impact factor: 5.103

Review 2.  Infectious bovine rhinotracheitis, parainfluenza-3, and respiratory coronavirus.

Authors:  S Kapil; R J Basaraba
Journal:  Vet Clin North Am Food Anim Pract       Date:  1997-11       Impact factor: 3.357

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.